Last week the FDA gave its blessing to Medicis to market their dermal filler Restylane for use by physicians in providing fuller lips. The approval makes Restylane the first hyaluronic acid dermal filler approved in the United States for lip augmentation. While many doctors have used it for lip augmentations in the recent past, it’s approved purpose (along side competitors Juvederm and Perlane) has been for filling in “tissue deficits” in the face – otherwise known as wrinkles and creases in the skin that tend to appear as a result of aging.
These and other fillers have been a welcome solution to the fight against wrinkles and sagging that occurs on the face over time. According to the American Society for Aesthetic Plastic Surgery, Americans received 1.3 million filler procedures and 2.4 million Botox injections in 2010. The popularity of these procedures is likely related to the visible difference that they make in the appearance of wrinkles on the face. They work by adding tissue-like substance to the dermis located underneath the epidermis layer of the skin. Whether the patient has a loose acne scar, a smile crease or a deep wrinkle, the filler is inserted underneath with a tiny needle, which helps to raise the epidermis layer in line with surrounding tissue or as desired by the injecting physician.
Once this is accomplished that deep fold or wrinkle, previously of great concern to the patient (or at least of enough concern to do something about), is diminished. By the numbers of these procedures performed every year, it appears that the patients are generally satisfied. According to some physicians however, the other side of that coin is that patients, no longer as focused on those wrinkles, now take greater note of their skin tone and texture.
“Once my wrinkles were gone, I realized how many little age spots or freckles I had on my face, and the rough texture of my skin.” Said a woman in her forties that we will call Jane. “It’s not that the Botox and fillers had any negative impact on my skin, but they didn’t improve my tone and texture either, and those aspects became more of a concern once I had invested so much in an effort to look younger.”
She is not alone in this experience. Some doctors have told this author that this complaint is common. The best way to avoid the issue is to treat the skin more comprehensively. There are a few medical grade products that your physician can provide to help improve your overall facial appearance. The best of these will focus on promoting healthy skin function, promoting exfoliation and helping the skin regulate it’s own production of melanin (which gives your skin it’s unique color) more evenly.
One physician-dispensed skincare system that does all of these things without using harsh ingredients (it is Hydroquinone-free) or irritating preservatives (it is paraben-free) is the Lumixyl Topical Brightening System.
Lumixyl is based on a class of peptides discovered by Stanford University researchers, and clinically shown to reduce the appearance of hyperpigmentation in patients.
The full system is comprised of four products including an anti-oxidant rich cleanser (a non-soap cleansing preparation), the peptide-rich brightening creme (to help reduce new hyperpigmentation from occurring), an exfoliating lotion (to improve skin turnover and promote better peptide penetration), and an SPF sunscreen (daily use of a good sunscreen is a must for long term skin health).
This powerful combination of products was only recently developed and made available to the public in 2010, yet it is already a standard offering for hundreds of dermatologists and cosmetic surgeons across the U.S. and in roughly 30 countries around the world. In addition to improving skin tone and texture, Lumixyl promotes healthier skin and may help the patient get a longer benefit from their Botox or filler treatments.
While hydroquinone products are still in wide use in the United States, Lumixyl provides a couple of key advantages. First, it is non-irritating and does not have the side effects of redness, flaking and scaling that commonly occur with hydroquinone products. Second, because it is completely non-toxic to skin, it can be used for as long as the patient wants the benefits of the product. In contrast, hydroquinone, while effective in the short-term under a physician’s care, is a prescription bleaching agent (at 4% or greater concentrations) that should not be used long-term, in order to avoid damaging skin.
If you are investing in fuller lips and better skin with the use of toxin and/or filler treatments, ask your physician about a skincare system that can help you get the most out of your investment in you.
More information on the Lumixyl Topical Brightening System and the exciting new Lumixyl SilkPeel procedure can be found HERE at the ENVY Medical website. To find a Lumixyl physician near you, click HERE.
About Lumixyl. Lumixyl is manufactured and marketed by Envy Medical, Inc. Envy Medical develops, markets and sells highly effective non-invasive skin rejuvenation therapies for patients suffering from either dermatologic or aesthetic conditions. The Company’s lead products include SilkPeel®, a breakthrough device combining exfoliation with Dermalinfusion™ for deeper tissue delivery of active ingredients and better patient outcomes. Envy is also the exclusive licensor of skin brightening peptides including Lumixyl, developed at Stanford University. The Lumixyl peptide is now also available in a topical solution for SilkPeel procedures, addressing hyperpigmentation and photo-damage. More information can be found at www.envymedical.com or by calling (888) 848-3633.
For media inquiries or to secure expert testimonial please contact Melissa Kelz, Principal, Melissa Kelz PR at email@example.com (312) 543-8300